Pubblicazioni

Bevacizumab as first-line treatment in HER2-negative advanced breast cancer. Pros and cons

2016 - TUMORI

Sini, Valentina; Cassano, Alessandra; Corsi, Domenico; De Laurentiis, Michele; Gamucci, Teresa; Mauri, Mariella; Naso, Giuseppe; Roselli, Mario; Ruggeri, Enzo Maria; Tonini, Giuseppe; Vici, Patrizia; Zampa, Germano; Marchetti, Paolo

Is the chemotherapy era in advanced non-small cell lung cancer really over? Maybe not yet

2016 - TUMORI

Lo Russo, Giuseppe; Imbimbo, Martina; Garassino, Marina Chiara